Parallel Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$1.24 - $2.33 $484 - $911	391 Added 103.71%	768 $2,000
Q1 2022 Apr 28, 2022	BUY	$2.0 - $4.9 $600 - $1,470	300 Added 389.61%	377 $1,000
Q1 2021 Apr 23, 2021	BUY	$7.03 - $16.51 $14 - $33	2 Added 2.67%	77 $1,000
Q4 2020 Feb 02, 2021	BUY	$5.76 - $11.95 $432 - $896	75 New	75 $1,000
Q2 2020 Jul 16, 2020	SELL	$1.73 - $6.76 $346 - $1,352	-200 Closed	0 $0

Q1 2020 Apr 27, 2020	SELL	$1.57 - $4.76 $471 - $1,428	-300 Reduced 60.0%	200 $0
Q3 2019 Nov 01, 2019	BUY	$2.05 - $2.69 $1,025 - $1,345	500 New	500 $1,000
Q2 2019 Aug 05, 2019	SELL	$2.67 - $4.38 $5,340 - $8,760	-2,000 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$1.86 - $5.94 $3,720 - $11,880	2,000 New	2,000 $10,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.